This inventor holds 1 USPTO granted patent. Top assignee: Novartis Ag. Active years: 2003.
Company Filing History:
Years Active: 2003
Title: Innovations in Diabetes Treatment by Urvi J Desai
Introduction
Urvi J Desai is an accomplished inventor based in Germantown, MD (US). She has made significant contributions to the field of diabetes treatment through her innovative research and patent work. Her dedication to improving health outcomes for diabetic patients is evident in her latest patent.
Latest Patents
Urvi J Desai holds a patent for "Methods and compositions for treatment of diabetes and related conditions via gene therapy." This patent discloses methods and compositions aimed at treating diabetes, obesity, and diabetic-related conditions. The methods involve gene therapy-based administration of a therapeutically effective amount of vectors encoding glucokinase regulatory protein, glucokinase, and metabolism-modifying proteins. These proteins include UCP2, UCP3, PPARα, OB-Rb, GLP-1, and GLP-1 analogs. Preferred examples of GLP-1 analogs mentioned in the patent include GLP-1-Gly8, Extendin-4, and the "Black Widow" chimeric GLP-1 analog. Additionally, the patent discusses the co-administration of PPARα ligands and DPP-IV inhibitors to enhance treatment efficacy.
Career Highlights
Urvi J Desai is currently employed at Novartis AG, where she continues to advance her research in diabetes treatment. Her work at Novartis AG allows her to collaborate with leading experts in the field and contribute to groundbreaking innovations.
Collaborations
Some of her notable coworkers include Shari Lynn Caplan and Brian R Boettcher. Their collaboration fosters a dynamic research environment that encourages the development of new therapeutic strategies.
Conclusion
Urvi J Desai's innovative work in gene therapy for diabetes treatment exemplifies her commitment to improving patient care. Her patent reflects a significant advancement in the field, showcasing her expertise and dedication to addressing critical health challenges.